An Open-Label Study of Vascazen in Cardiac Rehab Patients With Deficient Blood Omega-3 Fatty Acid Levels

NCT02052986 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Dyslipidemia

Interventions

OTHER: VASCAZEN

Sponsor

New York Hospital Queens

Collaborators

[object Object]
[object Object]